113 related articles for article (PubMed ID: 2316402)
1. Iliac bone biopsies at the time of periarticular stress fractures during fluoride therapy: comparison with pretreatment biopsies.
Schnitzler CM; Mesquita JM; Gear KA; Robson HJ; Moodley GP; Smyth AE
J Bone Miner Res; 1990 Feb; 5(2):141-52. PubMed ID: 2316402
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for the development of stress fractures during fluoride therapy for osteoporosis.
Schnitzler CM; Wing JR; Mesquita JM; Gear AK; Robson HJ; Smyth AE
J Bone Miner Res; 1990 Mar; 5 Suppl 1():S195-200. PubMed ID: 2339629
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous hip fractures in fluoride-treated patients: potential causative factors.
Gutteridge DH; Price RI; Kent GN; Prince RL; Michell PA
J Bone Miner Res; 1990 Mar; 5 Suppl 1():S205-15. PubMed ID: 2339631
[TBL] [Abstract][Full Text] [Related]
4. [Stress fractures during fluoride therapy. Physiopathological value of histomorphometry].
Toussirot E; Schiano A; Lafforgue P; Acquaviva PC; Roux H
Rev Rhum Mal Osteoartic; 1991 Oct; 58(9):571-5. PubMed ID: 1775903
[TBL] [Abstract][Full Text] [Related]
5. [Histological effects of the treatment of osteoporosis with the combination of sodium fluoride, vitamin D and calcium].
Briançon D; Charhon S; Edouard C; Meunier PJ
Rev Rhum Mal Osteoartic; 1980 Dec; 47(12):693-8. PubMed ID: 7006045
[TBL] [Abstract][Full Text] [Related]
6. The microscopic morphology of fluoride-induced bone.
Vigorita VJ; Suda MK
Clin Orthop Relat Res; 1983; (177):274-82. PubMed ID: 6407795
[TBL] [Abstract][Full Text] [Related]
7. [Loss of trabecular bone strength and bone quality after 5 years of fluoride therapy for osteoporosis].
Søgaard CH; Mosekilde L; Richards A; Mosekilde L
Ugeskr Laeger; 1995 Apr; 157(14):2004-8. PubMed ID: 7740640
[TBL] [Abstract][Full Text] [Related]
8. Bone density, histomorphometry and biochemistry in patients with fractures of the hip or spine.
Härmä M; Parviainen M; Koskinen T; Hoikka V; Alhava E
Ann Clin Res; 1987; 19(6):378-82. PubMed ID: 3451690
[TBL] [Abstract][Full Text] [Related]
9. Treatment of osteoporosis with sodium fluoride and calcium: effects on vertebral fracture incidence and bone histomorphometry.
Lane JM; Healey JH; Schwartz E; Vigorita VJ; Schneider R; Einhorn TA; Suda M; Robbins WC
Orthop Clin North Am; 1984 Oct; 15(4):729-45. PubMed ID: 6493736
[TBL] [Abstract][Full Text] [Related]
10. An analysis of bone structure in patients with hip fracture.
Uitewaal PJ; Lips P; Netelenbos JC
Bone Miner; 1987 Oct; 3(1):63-73. PubMed ID: 3505194
[TBL] [Abstract][Full Text] [Related]
11. Increased incidence of hip fracture in osteoporotic women treated with sodium fluoride.
Hedlund LR; Gallagher JC
J Bone Miner Res; 1989 Apr; 4(2):223-5. PubMed ID: 2728925
[TBL] [Abstract][Full Text] [Related]
12. Vertebral fractures are associated with increased cortical porosity in iliac crest bone biopsy of men with idiopathic osteoporosis.
Ostertag A; Cohen-Solal M; Audran M; Legrand E; Marty C; Chappard D; de Vernejoul MC
Bone; 2009 Mar; 44(3):413-7. PubMed ID: 19071239
[TBL] [Abstract][Full Text] [Related]
13. Stress fractures of the lower limbs in osteoporotic patients treated with fluoride.
Orcel P; de Vernejoul MC; Prier A; Miravet L; Kuntz D; Kaplan G
J Bone Miner Res; 1990 Mar; 5 Suppl 1():S191-4. PubMed ID: 2339628
[TBL] [Abstract][Full Text] [Related]
14. Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84.
Recker RR; Bare SP; Smith SY; Varela A; Miller MA; Morris SA; Fox J
Bone; 2009 Jan; 44(1):113-9. PubMed ID: 18983947
[TBL] [Abstract][Full Text] [Related]
15. The effect of fluoride on bone histology in postmenopausal osteoporosis depends on adequate fluoride absorption and retention.
Budden FH; Bayley TA; Harrison JE; Josse RG; Murray TM; Sturtridge WC; Kandel R; Vieth R; Strauss AL; Goodwin S
J Bone Miner Res; 1988 Apr; 3(2):127-32. PubMed ID: 3213607
[TBL] [Abstract][Full Text] [Related]
16. Comparison of nonrandomized trials with slow-release sodium fluoride with a randomized placebo-controlled trial in postmenopausal osteoporosis.
Pak CY; Adams-Huet B; Sakhaee K; Bell NH; Licata A; Johnston C; Rubin B; Bonnick S; Piziak V; Graham H; Ballard J; Berger R; Fears W; Breslau N; Rubin C
J Bone Miner Res; 1996 Feb; 11(2):160-8. PubMed ID: 8822339
[TBL] [Abstract][Full Text] [Related]
17. Treatment of vertebral osteoporosis with disodium monofluorophosphate: comparison with sodium fluoride.
Delmas PD; Dupuis J; Duboeuf F; Chapuy MC; Meunier PJ
J Bone Miner Res; 1990 Mar; 5 Suppl 1():S143-7. PubMed ID: 2339624
[TBL] [Abstract][Full Text] [Related]
18. Effect of intermittent therapy with a slow-release fluoride preparation.
Pak CY; Sakhaee K; Zerwekh JE
J Bone Miner Res; 1990 Mar; 5 Suppl 1():S149-55. PubMed ID: 2339625
[TBL] [Abstract][Full Text] [Related]
19. Fluoride treatment of postmenopausal osteoporosis: age, renal function, and other clinical factors in the osteogenic response.
Murray TM; Harrison JE; Bayley TA; Josse RG; Sturtridge WC; Chow R; Budden F; Laurier L; Pritzker KP; Kandel R
J Bone Miner Res; 1990 Mar; 5 Suppl 1():S27-35. PubMed ID: 2339633
[TBL] [Abstract][Full Text] [Related]
20. Effect and safety of intermittent weekly administration of human parathyroid hormone 1-34 in patients with primary osteoporosis evaluated by histomorphometry and microstructural analysis of iliac trabecular bone before and after 1 year of treatment.
Miki T; Nakatsuka K; Naka H; Masaki H; Imanishi Y; Ito M; Inaba M; Morii H; Nishizawa Y
J Bone Miner Metab; 2004; 22(6):569-76. PubMed ID: 15490267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
